# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marcus Aurelius (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC004-SYN
- Date: 2026-08-25
- Fictional facility: St. Posthumous Health Center
- Fictional author: Octavia Ashworth-Nnamdi, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Fifteen-week review: on-demand omeprazole, sleep, the remedy, and mood. **S**

## History of present illness

Mr. Aurelius returns six weeks after finishing the eight-week omeprazole course. He has taken omeprazole on demand about once a week, after a late dinner, and has had no chest or epigastric pain otherwise. His appetite is good and he has regained most of the weight he had lost. He has finished six CBT-I sessions and sleeps about six and a half hours, falling asleep within twenty minutes. About four weeks ago he chose to take the herbal paste on only two nights a week, a smaller amount, and noticed only a night or two of lighter sleep. He has no craving and takes no more on the nights he uses it. The COVID-19 illness in July left no after-effects. He says he feels clearer in the mornings and is working shorter evenings. **S**

| Element | Detail |
|---|---|
| Reflux | On-demand omeprazole about once a week; no pain otherwise |
| Sleep | Six CBT-I sessions completed; Insomnia Severity Index 7 |
| Remedy | About two nights a week, smaller amount, for four weeks, by his choice; no craving |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight regained; energy good |
| Gastrointestinal | Positive | Occasional heartburn after a late dinner, eased by omeprazole; no difficulty swallowing, vomiting or black stools |
| Cardiovascular | Negative | No chest pain |
| Psychiatric | Negative | Mood good; sleeping better; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 **S**
- Omeprazole 20 mg delayed-release capsule, one capsule by mouth before breakfast on days after heartburn returns (on-demand therapy after the eight-week course) **S**
- Opium-containing compounded herbal paste (unregulated, strength unknown), a smaller amount, about 0.3 g, by mouth at bedtime on about two nights a week, a further reduction he chose **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/76 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 65 kg; BMI 22 kg/m². All vital signs are synthetic.

PHQ-9: 3; GAD-7: 3. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 3 at this visit **S**
- GAD-7: 6 at baseline, 3 at this visit **S**

## Immunizations given today

- Hepatitis B vaccine (HepB-CpG), dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 65.0 kg, BMI 22.0; pulse 70, blood pressure 118/76 |
| Abdomen | Soft and non-tender |
| Neurological | Calm; no signs of withdrawal |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Reflux esophagitis, healed clinically, on on-demand therapy** (K21.00). Grade B esophagitis treated for eight weeks with resolution of symptoms; on-demand omeprazole about once a week controls the occasional heartburn after late meals. No alarm features, so no repeat endoscopy; manometry and reflux monitoring are not needed while he is well. **S**
   - Omeprazole on demand; return if heartburn comes back most days, for a trial of daily therapy at the lowest dose.
   - Keep the early evening meal.
2. **Chronic insomnia, in remission after CBT-I** (G47.00). Insomnia Severity Index 7, below the threshold for clinical insomnia, after six sessions. **S**
   - Keep the fixed rising time and the sleep-diary skills; a booster session if sleep slips.
3. **Opium-containing remedy, about two nights a week by his choice** (F11.90). He has reduced his use step by step at his own pace and is sleeping better with less of it. No DSM-5-TR criterion is present now. The paste is still unregulated and of unknown strength. **S**
   - Any further change is his decision; the clinic will support stopping, staying where he is, or a slow taper.
   - Never a larger amount after nights off; naloxone at the bedside.
   - A urine drug test again in a year, with his consent; review at each visit.
4. **Strain of command and mood** (Z56.6). PHQ-9 3 and GAD-7 3, down from 8 and 6 at intake. **S**
   - Keep the protected evening hours.
5. **Constipation from the opioid** (K59.03). Rarely needs the laxative now that he takes the remedy less often. **S**
   - Polyethylene glycol as needed.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Reflux symptoms: heartburn, chest pain after meals, regurgitation, night waking | Every visit | Completed today | Occasional heartburn after late dinners only |
| Examination | Alarm features: difficulty or pain swallowing, bleeding, vomiting, weight loss, anemia | Every visit | Completed today | None; weight 65.0 kg |
| Medication safety | Proton pump inhibitor: dose, timing before breakfast, and adherence | Eight weeks for erosive esophagitis, then the lowest effective dose or on demand | Completed today | Eight-week course finished; on demand about once a week |
| Imaging | Repeat endoscopy | Only for Los Angeles grade C or D esophagitis or new alarm features | Not indicated | Grade B esophagitis with no alarm features |
| Self-management | Meal timing, head-of-bed elevation, alcohol at night | Every visit | Completed today | Early main meal; head of bed raised |
| Medication safety | Opium-containing remedy: amount, pattern, benefits and harms, his own goals | Every visit | Completed today | About two nights a week, a smaller amount, by his choice |
| Medication safety | Reassessment after a change in opioid use | Within one to four weeks of a change | Completed today | Reviewed about four weeks after his last change; reviewed at the sick and preventive visits after the first |
| Medication safety | Naloxone at home and no alcohol or sedatives with the remedy | Every visit | Completed today | In date at the bedside |
| Medication safety | DSM-5-TR opioid use disorder criteria | At intake and when the pattern changes | Completed today | No criterion present |
| Laboratory | Urine drug test with consent | At intake, then at least yearly while he uses an opioid | Up to date | Intake test showed morphine and codeine only; next in a year, with consent |
| Survey | Suicide risk and safety review | Every visit | Completed today | No thoughts of self-harm |
| Survey | PHQ-9 and GAD-7 | At intake, at follow-up and at the end of the episode | Completed today | PHQ-9 3; GAD-7 3 |
| Survey | Insomnia Severity Index | At intake and at each review | Completed today | 7, below the threshold for clinical insomnia |
| Self-management | Cognitive behavioral therapy for insomnia (six sessions) with sleep diary | Six sessions | Completed today | All six sessions completed |
| Self-management | Constipation on the opioid | Every visit | Completed today | Laxative rarely needed |
| Laboratory | Cardiovascular risk and statin decision | Every four to six years by the PREVENT equations | Up to date | Low risk with a calcium score of 0; no statin |
| Medication safety | Hepatitis B vaccine, dose 2 | At least four weeks after dose 1 | Completed today | HepB-CpG dose 2 given today |

## Goal progress

- A cardiac cause of the chest pain excluded within two weeks. Outcome by 2026-05-19: Normal ECG at intake; CT coronary angiography one week later: calcium score 0 and no plaque. **S**
- Chest and stomach pain after meals controlled, with appetite and weight returning. Outcome by 2026-08-25: Pain gone on omeprazole; occasional mild heartburn after late meals on on-demand therapy; weight up 2 kg. **S**
- Insomnia Severity Index below 8 within four months. Outcome by 2026-08-25: Insomnia Severity Index 7 after six sessions of CBT-I. **S**
- The remedy used as safely as he can: naloxone at home, never with alcohol or sleep medicines, and decisions about it his own. Outcome by 2026-08-25: Naloxone at home; no alcohol on nights he takes it; by his own choice now about two nights a week. **S**

## Guideline basis

- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (2022), American College of Gastroenterology (Am J Gastroenterol 2022;117(1):27-56)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021), American Academy of Sleep Medicine (J Clin Sleep Med 2021;17(2):255-262)
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Ann Intern Med 2016;165(2):125-133)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, hyperlipidemia and ischemic heart disease monographs (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Review in six months, or sooner if heartburn returns most days, sleep slips, or he wants help with the remedy. Second zoster dose in two to six months after the first; influenza vaccine in the autumn; colonoscopy as ordered. **S**

